Cite
Iodine-131-Labeled Fibronectin: Potential Agent for Imaging Atherosclerotic Lesion and Thrombus.
MLA
Uehara, Akira, et al. “Iodine-131-Labeled Fibronectin: Potential Agent for Imaging Atherosclerotic Lesion and Thrombus.” Journal of Nuclear Medicine, vol. 29, no. 7, July 1988, pp. 1264–67. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=82568003&authtype=sso&custid=ns315887.
APA
Uehara, A., Isaka, Y., Hashikawa, K., Kimura, K., Kozuka, T., Kamada, T., Etani, H., Yoneda, S., & Imaizumi, M. (1988). Iodine-131-Labeled Fibronectin: Potential Agent for Imaging Atherosclerotic Lesion and Thrombus. Journal of Nuclear Medicine, 29(7), 1264–1267.
Chicago
Uehara, Akira, Yoshinari Isaka, Kazuo Hashikawa, Kazufumi Kimura, Takahiro Kozuka, Takenobu Kamada, Hideki Etani, Shotaro Yoneda, and Masatoshi Imaizumi. 1988. “Iodine-131-Labeled Fibronectin: Potential Agent for Imaging Atherosclerotic Lesion and Thrombus.” Journal of Nuclear Medicine 29 (7): 1264–67. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=82568003&authtype=sso&custid=ns315887.